Chemokine receptor CCR2 but not CCR5 or CCR6 mediates the increase in pulmonary dendritic cells during allergic airway inflammation

被引:92
|
作者
Robays, Lander J.
Maes, Tania
Lebecque, Serge
Lira, Sergio A.
Kuziel, William A.
Brusselle, Guy G.
Joos, Guy F.
Vermaelen, Karim V.
机构
[1] State Univ Ghent Hosp, Dept Resp Dis, B-9000 Ghent, Belgium
[2] INSERM, Unite 503, Ctr Etud & Rech Virol & Immunol, Lyon, France
[3] CUNY Mt Sinai Sch Med, Immunobiol Ctr, New York, NY 10029 USA
[4] PDL BioPharma, Fremont, CA 94555 USA
来源
JOURNAL OF IMMUNOLOGY | 2007年 / 178卷 / 08期
关键词
D O I
10.4049/jimmunol.178.8.5305
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Increased numbers of pulmonary dendritic cells (DCs) are recruited to the lungs during allergic airway inflammation and contribute to the maintenance of the inflammatory immune response. The chemokine receptors that directly control DC accumulation into the lungs are largely unknown. To explore this issue, we generated mixed bone marrow chimeric mice containing both wild-type and knockout cells for a given chemokine receptor. After induction of allergic airway Inflammation, we specifically tracked and compared chemokine receptor knockout vs wild-type DC populations through various lung compartments. Using this approach, we show that CCR2, but not CCR5 or CCR6, directly controls the accumulation of DCs into allergic lungs. Furthermore, the size of inflammatory monocyte populations in peripheral blood was strikingly CCR2 dependent, suggesting that CCR2 primarily mediates the release of monocytic DC precursors into the bloodstream.
引用
收藏
页码:5305 / 5311
页数:7
相关论文
共 50 条
  • [21] Polymorphism of CC chemokine receptors CCR5 and CCR2 in Crohn's disease
    Oppermann, M
    Herfarth, H
    Göke, M
    Press, A
    Pollok-Kopp, B
    FASEB JOURNAL, 2001, 15 (04): : A358 - A358
  • [22] CCR2, CCR5, their ligands and chemokine receptor-interacting protein FROUNT have impressive effects on pulmonary adenocarcinoma
    Itakura, Meiji
    Shingyoji, Masato
    Iizasa, Toshihiko
    Yoshida, Yasushi
    Ashinuma, Hironori
    Miriya, Yasumitsu
    Tamura, Hajime
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [23] Impact of polymorphisms for the chemokine receptors CCR2 and CCR5 in kidney graft survival
    Mytilineos, J
    Forssmann, U
    Laux, G
    Opelz, G
    HUMAN IMMUNOLOGY, 2004, 65 : S100 - S100
  • [24] Expression of the chemokine receptor CCR6 in human renal inflammation
    Segerer, S.
    Welsh-Bacic, D.
    Lindenmeyer, M.
    Cohen, C. D.
    Ziegler, U.
    Regele, H.
    Wuethrich, R. P.
    SWISS MEDICAL WEEKLY, 2009, 139 (45-46) : 16S - 16S
  • [25] Expression of the chemokine receptor CCR6 in human renal inflammation
    Welsh-Bacic, Desa
    Lindenmeyer, Maja
    Cohen, Clemens D.
    Draganovici, Dan
    Mandelbaum, Jana
    Edenhofer, Ilka
    Ziegler, Urs
    Regele, Heinz
    Wuethrich, Rudolf P.
    Segerer, Stephan
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2011, 26 (04) : 1211 - 1220
  • [26] Gene conversion between mammalian CCR2 and CCR5 chemokine receptor genes:: A potential mechanism for receptor dimerization
    Vazquez-Salat, Nuria
    Yuhki, Naoya
    Beck, Thomas
    O'Brien, Stephen J.
    Murphy, William J.
    GENOMICS, 2007, 90 (02) : 213 - 224
  • [27] Possible contribution of chemokine receptor CCR2 and CCR5 polymorphisms in the pathogenesis of chronic spontaneous autoreactive urticaria
    Brzoza, Z.
    Grzeszczak, W.
    Rogala, B.
    Trautsolt, W.
    Moczulski, D.
    ALLERGOLOGIA ET IMMUNOPATHOLOGIA, 2014, 42 (04) : 302 - 306
  • [28] Genetic polymorphism of chemokine receptors CCR2 and CCR5 in Swedish cervical cancer patients
    Zheng, Biying
    Wiklund, Fredrik
    Gharizadeh, Baback
    Sadat, Mehdi
    Gambelunghe, Giovanni
    Hallmans, Goran
    Dillner, Joakim
    Wallin, Keng-Ling
    Ghaderi, Mehran
    ANTICANCER RESEARCH, 2006, 26 (5B) : 3669 - 3674
  • [29] Elucidation of Binding Sites of Dual Antagonists in the Human Chemokine Receptors CCR2 and CCR5
    Hall, Spencer E.
    Mao, Allen
    Nicolaidou, Vicky
    Finelli, Mattea
    Wise, Emma L.
    Nedjai, Belinda
    Kanjanapangka, Julie
    Harirchian, Paymann
    Chen, Deborah
    Selchau, Victor
    Ribeiro, Sofia
    Schyler, Sabine
    Pease, James E.
    Horuk, Richard
    Vaidehi, Nagarajan
    MOLECULAR PHARMACOLOGY, 2009, 75 (06) : 1325 - 1336
  • [30] Rationale of using the dual chemokine receptor CCR2/CCR5 inhibitor cenicriviroc for the treatment of COVID-19
    Files, Daniel Clark
    Tacke, Frank
    O'Sullivan, Alexandra
    Dorr, Patrick
    Ferguson, William G.
    Powderly, William G.
    PLOS PATHOGENS, 2022, 18 (06)